Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis

NCT07146087 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

SUSPENDED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Slow enrolment of participants

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: MSC-Derived Exosomes
BIOLOGICAL: Placebo (Normal Saline)

Sponsor

Biocells Medical